Center for Tissue Engineering, Chang Gung Memorial Hospital Linkou Medical Center, Kweishan, Taoyuan, Taiwan.
Division of Reconstructive Microsurgery, Department of Plastic and Reconstructive Surgery, Chang Gung Memorial Hospital Linkou Medical Center, Kweishan, Taoyuan, Taiwan.
Tissue Eng Part A. 2022 Aug;28(15-16):685-699. doi: 10.1089/ten.TEA.2021.0193.
Tracheal reconstruction remains challenged in clinical. We aimed to fabricate scaffolded cartilage sheets with rigid and elastic supports for tracheal reconstruction. The chondrocyte cell infiltration activity was examined in poly-caprolactone sheet scaffolds with various thicknesses and pore sizes after seeding cells on the top surface of the sheet scaffolds. The expression of cartilage-related genes and accumulation of sulfated glycosaminoglycans were elevated in the cell-scaffold composites upon chondrogenic induction. The thicker cartilage sheets represented stronger mechanical properties than the thinner cartilage sheets. Two different cartilage sheets were orthotopically implanted into a trachea in a rabbit model for 2, 4, and 16 weeks. Cartilage-related sulfated glycosaminoglycans and type II collagen macromolecules were stably expressed in the tracheal implants. However, the invasive migration of fibrous tissue and profibrotic collagen fibers into cartilage implants and the peripheral space surrounding the implants were elevated in a time-dependent manner. At week 16 postimplantation, airway stenosis was noticed under the thicker sheet implants, but not the thinner implants, suggesting that the thinner (1 mm thick) scaffolded cartilage sheet was an optimal candidate for tracheal reconstruction in this study. Finally, cartilage sheets could be a reconstructive therapy candidate applied to reconstruct defects in the trachea and other tissues composed of cartilage. Impact statement Tissue engineering is a promising approach to generate biological substitutes. We aimed to develop cartilage sheets as tracheal prosthesis used in tracheal reconstruction or regional repairing in the animal model. The formation of microvessels and the dynamics of reepithelialization were monitored for 16 weeks in tracheal implants of the engineered cartilage sheets. In this study, it was demonstrated that the tissue-engineered cartilage sheets are potential substitutes applied in the reconstruction of the trachea and other tissues composed of cartilage tissue. The cartilage sheets were thought of as biomaterials for personalized regenerative medicine since the dimensions, thickness, and pore sizes of cartilage sheets were tunable to fit the lesions that need to be reconstructed.
气管重建在临床上仍然具有挑战性。我们旨在制造具有刚性和弹性支撑的支架化软骨片,用于气管重建。在将细胞接种到片材支架的顶表面上之后,检查了具有不同厚度和孔径的聚己内酯片材支架中的细胞渗透活性。在软骨形成诱导下,细胞-支架复合物中软骨相关基因的表达和硫酸化糖胺聚糖的积累增加。较厚的软骨片代表比较薄的软骨片更强的机械性能。两种不同的软骨片在兔模型中分别植入气管内 2、4 和 16 周。在气管植入物中稳定表达了与软骨相关的硫酸化糖胺聚糖和 II 型胶原蛋白大分子。然而,纤维组织和纤维增生性胶原纤维向软骨植入物和植入物周围的外周空间的侵入性迁移随时间增加而增加。在植入后 16 周,在较厚片材植入物下注意到气道狭窄,但在较薄植入物下没有,这表明在这项研究中,较薄(1 毫米厚)的支架化软骨片是气管重建的最佳候选物。最后,软骨片可以作为一种重建疗法候选物,应用于气管和其他由软骨组成的组织的重建。 影响说明 组织工程是生成生物替代品的一种有前途的方法。我们旨在开发软骨片作为气管假体,用于动物模型中的气管重建或区域性修复。在工程化软骨片中监测了微脉管系统的形成和再上皮化的动力学16 周。在这项研究中,证明了组织工程软骨片是潜在的替代品,可应用于气管和其他由软骨组织组成的组织的重建。由于软骨片的尺寸、厚度和孔径可调以适应需要重建的病变,因此软骨片被认为是个性化再生医学的生物材料。